Clinical Leader Webinar

  1. How DHTs Can Facilitate Widespread Outpatient Immunotherapy Treatments 6/6/2025

    In this presentation, a panel of experts explores how the industry is leveraging digital innovation to manage immunotherapy risks and the critical next steps toward deploying scalable, technology-driven CRS monitoring solutions.

  2. The Role Of Technology In Improving Site Performance 5/29/2025

    Explore how clinical trial sponsors can benefit from the growing use of electronic source (eSource) technology at research sites.

  3. The Future Of AI Analytics On Chronic Pain And Neurological DHTs In Clinical Research 5/27/2025

    This presentation explores how DHTs and AI-driven diagnostics are transforming clinical research, supporting more accurate assessments and accelerating therapeutic development in chronic pain and neurological disorders.

  4. At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights 5/20/2025

    Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

  5. Mastering The Complexities Of Gene Therapy Document Writing 5/20/2025

    Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.

  6. The Top 5 Myths About eCOAs In 2025 5/15/2025

    Join leading clinical experts as they debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter decisions.

  7. Achieving Regulatory Compliance With A Unified Immunogenicity Strategy 5/10/2025

    This presentation equips viewers with the knowledge and tools needed to navigate the intricacies of designing immunogenicity assays that comply with both European IVDR and US FDA regulations.

  8. The Value Of Continuous Cough Monitoring And Its Impact On The Placebo Effect 5/9/2025

    This presentation explores how digital health technologies are transforming the way persistent cough is monitored and understood across various respiratory diseases.

  9. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  10. Assessing Diversity In Early-Phase Clinical Trials In A Rapidly Changing Regulatory Environment 5/5/2025

    Learn more about structuring early-phase trials to address population variation and the contributing factors to safe drug administration, both of which are essential to a drug development plan.